Skip to main content

Table 6 Non-adjusted and age/diagnosis adjusted odds ratio for pharmacological secondary prevention in men with respect to women

From: Ischemic heart disease and primary care: identifying gender-related differences. An observational study

 

ORunadj

C.I. 95%

ORadj

C.I. 95%

Any medication

1.63*

(1.24–2.13)

1.43*

(1.07–1.92)

Anticoagulants

1.93*

(1.53–2.43)

1.81*

(1.41–2.31)

Beta blockers

1.33*

(1.10–1.62)

1.03

(0.84–1.27)

ACE inhibitors/ARB

1.20

(0.99–1.45)

1.15

(0.94–1.42)

Lipid-lowering agents

1.70*

(1.39–2.05)

1.24*

(1.01–1.53)

  1. *p-value < 0,05 in the model adjusted for age and IHD specific diagnosis (chronic ischemic heart disease, acute myocardial infarction and angina)
  2. Estimated age-adjusted OR using GAM link logit